Zurcher Kantonalbank (Zurich Cantonalbank) Next Cure, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$7.6 - $10.28 $2,660 - $3,598	-350 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$9.81 - $13.88 $189,313 - $267,856	-19,298 Reduced 98.22%	350 $4,000
Q3 2020 Nov 06, 2020	BUY	$8.15 - $21.17 $160,131 - $415,948	19,648 New	19,648 $173,000

Others Institutions Holding NXTC

# of Institutions

Shares Held

15.8M

Call Options Held

Put Options Held

Sofinnova Investments, Inc. Menlo Park, CA

2.67M
Shares

$2.11 Million
0.35% of portfolio
Logos Global Management LP San Francisco, CA

2.5M
Shares

$1.98 Million
0.45% of portfolio
Affinity Asset Advisors, LLC New York, NY

2.3M
Shares

$1.82 Million
0.54% of portfolio
Orbimed Advisors LLC San Diego, CA

1.14M
Shares

$901,548
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

987K
Shares

$779,985
0.0% of portfolio

View Full List

About NextCure, Inc.

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $21.9M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

More about NXTC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account